UniProt/SwissProt ID: | LRP1_HUMAN |
Description: | low density lipoprotein receptor-related protein 1 [Source:HGNC Symbol;Acc:6692] |
Location: | chr12 q13.3 |
Node attribute: | receptor; substrate |
Phosphorylation site |
Position | PhosphoPeptide | Catalytic kinase | Source |
---|---|---|---|
S1432 | HRETGsGGWPN | Ldl_recept_b | PhosphoSitePlus |
S4517 | MGGHGsRHSLA | PhosphoSitePlus; RegPhos | |
Y1443 | GLTVDyLEKRI | Ldl_recept_b | PhosphoSitePlus |
Y4507 | FTNPVyATLYM | PhosphoSitePlus; RegPhos | |
S1754 | IDFPEsKLYWI | PhosphoSitePlus | |
T648 | IEGKMtHPRAI | Ldl_recept_b | PhosphoSitePlus |
Y4473 | IGNPTyKMYEG | PhosphoSitePlus | |
T1430 | TVHREtGSGGW | Ldl_recept_b | PhosphoSitePlus |
Y530 | ELFLVyGKGRP | PhosphoSitePlus | |
S4249 | GTCAAsPSGMP | EGF | PhosphoSitePlus |
T2156 | DRQKGtNVCAV | PhosphoSitePlus | |
S4517 | MGGHGsRHSLA | PKA_group | phosphoELM; RegPhos |
Y4507 | FTNPVyATLYM | Src | RegPhos |
S4520 | HGSRHsLASTD | PKACa | RegPhos |
S4520 | HGSRHsLASTD | PKA_group | phosphoELM; RegPhos |
Y2290 | VEGLAyHRGWD | PhosphoSitePlus | |
T4460 | QHQRMtNGAMN | PhosphoSitePlus; RegPhos | |
S4523 | RHSLAsTDEKR | PhosphoSitePlus; HPRD; RegPhos | |
S4067 | ADAKLsVIGSI | Ldl_recept_b | PhosphoSitePlus |
T1790 | QLGKAtALAIM | PhosphoSitePlus | |
T1513 | TGHNVtVVQRT | PhosphoSitePlus; HPRD | |
S2621 | TCIGNsSRCNQ | Ldl_recept_a | PhosphoSitePlus |
T1498 | WTDWRtNTLAK | PhosphoSitePlus | |
S3217 | YIEFAsLDGSN | HPRD | |
S4520 | HGSRHsLASTD | PhosphoSitePlus; RegPhos | |
Y1587 | KKFLLyARQME | PhosphoSitePlus | |
Y4507 | FTNPVyATLYM | SRC | HPRD; phosphoELM; RegPhos |
S3928 | TISYRsLPPAA | PhosphoSitePlus | |
S4520 | HGSRHsLASTD | PRKACA | HPRD |
S4071 | LSVIGsIRLNG | Ldl_recept_b | PhosphoSitePlus |
T1440 | WPNGLtVDYLE | Ldl_recept_b | PhosphoSitePlus |
Y4511 | VYATLyMGGHG | PhosphoSitePlus | |
T1500 | DWRTNtLAKAN | PhosphoSitePlus; HPRD | |
Dephosphorylation site |
LRP1_HUMAN do not have dephosphorylation site. |
Mutation site |
Ensembl ID | Variation | Source | Cancer name | Pubmed |
---|---|---|---|---|
ENSP00000243077 | R3760H | HPI | Colorectal Cancer | 16959974 |
ENSP00000243077 | G4316V | COSMIC | Ovarian Cancer | 21720365 |
ENSP00000243077 | N2048K | COSMIC | Ovarian Cancer | 21720365 |
ENSP00000243077 | S970L | COSMIC | Melanoma | 21499247 |
ENSP00000243077 | E1369K | COSMIC | Ovarian Cancer | 21720365 |
ENSP00000243077 | T3738S | BIOMART | Pancreatic Cancer | 21930507, 21930502 |
ENSP00000243077 | P3733S | COSMIC | Breast Cancer | 20668451 |
ENSP00000243077 | L1893V | BIOMART | Breast Cancer | 21930507, 21930502 |
ENSP00000243077 | N3682S | COSMIC | Ovarian Cancer | 21720365 |
ENSP00000243077 | E869K | Sjoblom2006, COSMIC | Intestines Cancer | 16959974 |
ENSP00000243077 | K1109R | TCGA | Ovarian Cancer | 21720365, 18772890 |
ENSP00000243077 | R793* | COSMIC | Pancreatic Cancer | |
ENSP00000243077 | R3760H | Sjoblom2006, COSMIC | Intestines Cancer | 16959974 |
ENSP00000243077 | I2255M | BIOMART | Breast Cancer | 21930507, 21930502 |
ENSP00000243077 | A2633T | COSMIC | Ovarian Cancer | 21720365 |
ENSP00000243077 | G4316V | TCGA | Ovarian Cancer | 21720365, 18772890 |
ENSP00000243077 | R4176Q | COSMIC | Pancreatic Cancer | 21252315 |
ENSP00000243077 | R1423C | TCGA | Ovarian Cancer | 21720365, 18772890 |
ENSP00000243077 | T2979M | COSMIC | Ovarian Cancer | 20668451 |
ENSP00000243077 | P2379S | COSMIC | Skin Cancer | 21984974 |
ENSP00000243077 | E869K | HPI | Colorectal Cancer | 16959974 |
ENSP00000243077 | K1109R | COSMIC | Ovarian Cancer | 21720365 |
ENSP00000243077 | L2209V | BIOMART | Breast Cancer | 21930507, 21930502 |
ENSP00000243077 | Y574* | TCGA | Ovarian Cancer | 21720365, 18772890 |
ENSP00000243077 | Q981E | COSMIC | Lung Cancer | 20668451 |
ENSP00000243077 | I404L | COSMIC | Breast Cancer | 20668451 |
ENSP00000243077 | R2032C | BIOMART | Breast Cancer | 21930507, 21930502 |
ENSP00000243077 | R1281C | BIOMART | chronic lymphocytic leukemia | 21930507, 21930502 |
ENSP00000243077 | R1423C | COSMIC | Ovarian Cancer | 21720365 |
ENSP00000243077 | Y574* | COSMIC | Ovarian Cancer | 21720365 |
Differential expressed protein |
Ensembl ID | Cancer name | Design | Sample | Change | Ratio | Pubmed |
---|---|---|---|---|---|---|
ENSP00000243077 | Uterine Cancer | Normal vs. Cancer | tissue | Down | 17902640 | |
Hyperphosphorylation site |
LRP1_HUMAN do not have hyperphosphorylation site. |
Direct Interaction Pair |
Source | Target | Relationship | Resource |
---|---|---|---|
A2MG_HUMAN | LRP1_HUMAN | ligand -> receptor | HPMR |
CO3_HUMAN | LRP1_HUMAN | ligand -> receptor | HPMR |
MMP13_HUMAN | LRP1_HUMAN | ligand -> receptor | HPMR |
ANT3_HUMAN | LRP1_HUMAN | ligand -> receptor | HPMR |
TRFL_HUMAN | LRP1_HUMAN | ligand -> receptor | HPMR |
FA9_HUMAN | LRP1_HUMAN | ligand -> receptor | HPMR |
MMP9_HUMAN | LRP1_HUMAN | ligand -> receptor | HPMR |
PAI1_HUMAN | LRP1_HUMAN | ligand -> receptor | HPMR |
SFTA1_HUMAN | LRP1_HUMAN | ligand -> receptor | HPMR |
FA8_HUMAN | LRP1_HUMAN | ligand -> receptor | HPMR |
A1AT_HUMAN | LRP1_HUMAN | ligand -> receptor | HPMR |
IC1_HUMAN | LRP1_HUMAN | ligand -> receptor | HPMR |
AMRP_HUMAN | LRP1_HUMAN | ligand -> receptor | HPMR |
ENPL_HUMAN | LRP1_HUMAN | ligand -> receptor | HPMR |
UROK_HUMAN | LRP1_HUMAN | ligand -> receptor | HPMR |
TPA_HUMAN | LRP1_HUMAN | ligand -> receptor | HPMR |
ZAGL2_HUMAN | LRP1_HUMAN | kinase -> substrate | RegPhos |
KPCA_HUMAN | LRP1_HUMAN | kinase -> substrate | HPRD |
SRC_HUMAN | LRP1_HUMAN | kinase -> substrate | HPRD; RegPhos |
Function Annotation |
KEGG Pathway |
KEGG ID | Pathway |
---|---|
hsa05144 | Malaria |
hsa05010 | Alzheimer's disease |
Gene Ontology |
GO ID | GO_Term | Evidence | Ontology |
---|---|---|---|
GO:0014912 | negative regulation of smooth muscle cell migratio | IEA | biological_process |
GO:0005737 | cytoplasm | IEA | cellular_component |
GO:0008203 | cholesterol metabolic process | IEA | biological_process |
GO:0043277 | apoptotic cell clearance | ISS | biological_process |
GO:0016020 | membrane | IEA | cellular_component |
GO:0005905 | coated pit | IEA | cellular_component |
GO:0014912 | negative regulation of smooth muscle cell migratio | ISS | biological_process |
GO:0034185 | apolipoprotein binding | IPI | molecular_function |
GO:0032370 | positive regulation of lipid transport | ISS | biological_process |
GO:0035909 | aorta morphogenesis | IEA | biological_process |
GO:0042954 | lipoprotein transporter activity | NAS | molecular_function |
GO:0035909 | aorta morphogenesis | ISS | biological_process |
GO:0032429 | regulation of phospholipase A2 activity | ISS | biological_process |
GO:0032403 | protein complex binding | IDA | molecular_function |
GO:2000587 | negative regulation of platelet-derived growth fac | IEA | biological_process |
GO:0005634 | nucleus | IEA | cellular_component |
GO:0032374 | regulation of cholesterol transport | ISS | biological_process |
GO:0005887 | integral to plasma membrane | ISS | cellular_component |
GO:0005515 | protein binding | IPI | molecular_function |
GO:0005515 | protein binding | IEA | molecular_function |
GO:0030178 | negative regulation of Wnt receptor signaling path | ISS | biological_process |
GO:0010875 | positive regulation of cholesterol efflux | ISS | biological_process |
GO:2000587 | negative regulation of platelet-derived growth fac | ISS | biological_process |
GO:0032956 | regulation of actin cytoskeleton organization | ISS | biological_process |
GO:0032374 | regulation of cholesterol transport | IEA | biological_process |
GO:0043277 | apoptotic cell clearance | IEA | biological_process |
GO:0042953 | lipoprotein transport | NAS | biological_process |
GO:0005509 | calcium ion binding | IEA | molecular_function |
GO:0004872 | receptor activity | TAS | molecular_function |
GO:0005887 | integral to plasma membrane | IEA | cellular_component |
GO:0032429 | regulation of phospholipase A2 activity | IEA | biological_process |
GO:0032370 | positive regulation of lipid transport | IEA | biological_process |
GO:0010875 | positive regulation of cholesterol efflux | IEA | biological_process |
GO:0030178 | negative regulation of Wnt receptor signaling path | IEA | biological_process |
GO:0005509 | calcium ion binding | ISS | molecular_function |
GO:0070325 | lipoprotein particle receptor binding | IC | molecular_function |
GO:0032956 | regulation of actin cytoskeleton organization | IEA | biological_process |
GO:0097242 | beta-amyloid clearance | IEA | biological_process |
GO:0006898 | receptor-mediated endocytosis | IEA | biological_process |
GO:0097242 | beta-amyloid clearance | TAS | biological_process |